bf/NASDAQ:LXRX_icon.jpeg

NASDAQ:LXRX

Lexicon Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.94

16/05 20:00

Market Cap

445.76M

Beta: 1.33

Volume Today

1.59M

Avg: 593.73K

PE Ratio

−3.21

PFCF: −3.75

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.38M
-
2.38M
0%
974K
-
3.31M
240.25%
4.46M
34.63%
2.12M
52.45%
average payables
8.69M
-
11.39M
31.09%
16.39M
43.94%
36.30M
121.42%
55.26M
52.24%
37.71M
31.77%
14.97M
60.30%
8.82M
41.05%
7.31M
17.15%
9.77M
33.69%
average receivables
1.08M
-
912.50K
15.82%
973K
6.63%
4.20M
331.81%
6.16M
46.58%
5.37M
12.73%
31.23M
481.04%
28.46M
8.85%
204.50K
99.28%
21K
89.73%
book value per share
-13.70
-
3.72
127.16%
2.76
25.82%
1.52
45.08%
0.50
67.33%
-13.91
2,908.59%
-12.63
9.18%
1.41
111.17%
-10.21
824.04%
-9.59
6.09%
capex per share
-0.02
-
-0.00
95.54%
-0.01
738.35%
-0.00
74.68%
-0.00
2.59%
-0.00
58.57%
-0.00
26.58%
-0.00
19.10%
-0.01
968.02%
-0.01
4.56%
capex to depreciation
-0.60
-
-0.04
93.10%
-1.25
2,916.64%
-0.11
91.02%
-0.07
40.30%
-0.03
61.55%
-0.02
25.73%
-0.03
54.79%
-4.18
14,001.77%
-3.11
25.74%
capex to operating cash flow
0.02
-
0.00
94.40%
-0.00
565.54%
0.00
126.71%
0.00
6.50%
0.00
48.02%
-0.00
196.22%
0.00
198.93%
0.01
2,205.87%
0.01
6.36%
capex to revenue
-0.77
-
-0.00
99.55%
-0.01
99.95%
-0.00
60.40%
-0.00
8.94%
-0.00
40.45%
-0.00
85.54%
-0.00
1,568.23%
-4.10
112,905.84%
-9.54
132.82%
cash per share
3.01
-
7.09
135.47%
8.11
14.31%
6.22
23.22%
5.32
14.51%
2.27
57.43%
2.56
12.91%
1.37
46.28%
0.60
56.65%
0.83
40.18%
days of inventory on hand
374.42
-
685.75
83.15%
479.32
30.10%
days payables outstanding
11.08K
-
2.60K
76.52%
1.38K
47.13%
1.03K
24.78%
days sales outstanding
129.77
-
16.53
87.26%
2.56
84.53%
32.81
1,183.01%
19.50
40.59%
34.21
75.47%
64.07
87.29%
6.01
90.62%
17.15
185.39%
73.53
328.78%
debt to assets
0.08
-
0.23
186.24%
0.16
29.26%
0.21
32.00%
0.56
163.85%
0.86
53.22%
0.59
31.62%
0.06
89.34%
0.02
73.52%
0.28
1,609.60%
debt to equity
-0.02
-
0.38
1,839.66%
0.37
2.36%
0.64
74.12%
4.72
631.59%
-0.17
103.53%
-0.18
10.28%
0.08
144.62%
-0.00
101.87%
-0.03
2,170.65%
dividend yield
0.00
-
0.57
-
0.02
96.43%
earnings yield
-0.11
-
-0.21
82.92%
-0.00
98.35%
-0.10
2,799.51%
-0.12
26.06%
-0.17
38.21%
0.30
272.09%
-0.19
162.71%
-0.15
16.92%
-0.33
111.81%
-0.52
59.32%
enterprise value
816.36M
-
254.66M
68.81%
963.25M
278.25%
1.19B
23.68%
974.62M
18.19%
787.66M
19.18%
650.98M
17.35%
265.62M
59.20%
512.08M
92.79%
325.50M
36.44%
enterprise value over ebitda
-7.82
-
-3.05
61.05%
83.30
2,833.87%
-8.79
110.55%
-7.35
16.38%
-7.89
7.43%
3.75
147.54%
-1.51
140.20%
-5.89
290.24%
-3.28
44.26%
ev to operating cash flow
-8.96
-
-3.37
62.43%
5.21
254.80%
-6.78
230.12%
-5.26
22.50%
-5.30
0.82%
5.72
207.92%
-1.86
132.48%
-5.88
216.75%
-3.66
37.75%
ev to sales
367.40
-
11.14
96.97%
7.41
33.51%
14.30
92.96%
10.79
24.53%
12.46
15.50%
2.02
83.78%
11.07
447.69%
1.72K
15,423.11%
2.34K
36.27%
free cash flow per share
-1.27
-
-0.99
21.68%
1.77
279.01%
-1.69
195.39%
-1.76
4.17%
-1.41
20.34%
1.07
176.21%
-1.29
220.53%
-0.61
53.06%
-0.54
10.19%
free cash flow yield
-0.10
-
-0.16
54.92%
0.13
185.67%
-0.12
191.81%
-0.18
45.82%
-0.21
18.53%
0.26
221.93%
-0.38
246.26%
-0.15
59.26%
-0.28
85.27%
graham net net
1.60
-
4.68
192.25%
4.55
2.74%
3.21
29.38%
1.71
46.76%
-0.61
135.36%
0.15
124.22%
0.95
547.38%
0.44
54.09%
0.37
15.21%
graham number
20.92
-
10.49
49.88%
1.68
84.02%
6.81
306.77%
3.70
45.76%
18.88
410.77%
18.66
1.16%
4.48
75.97%
11.80
163.24%
11.59
1.81%
income quality
0.87
-
0.75
13.80%
-39.47
5,334.09%
1.24
103.15%
1.44
15.69%
1.23
14.19%
0.87
29.06%
2.44
179.10%
0.99
59.38%
0.87
12.10%
intangibles to total assets
0.36
-
0.21
41.96%
0.15
28.02%
0.21
37.68%
0.22
7.32%
0.33
50.82%
0.15
53.83%
0.22
42.08%
0.33
48.85%
0.23
29.54%
0
100%
interest coverage
-51.94
-
-44.55
14.23%
0.22
100.49%
-20.89
9,663.50%
-19.57
6.30%
-4.97
74.60%
6.84
237.62%
-12.29
279.69%
-108.59
783.38%
-36.24
66.62%
-14.82
59.11%
interest debt per share
0.33
-
1.44
342.54%
1.09
24.55%
1.04
4.26%
2.40
130.85%
2.51
4.61%
2.51
0.08%
0.25
90.18%
0.02
91.43%
0.35
1,556.52%
inventory turnover
0.97
-
0.53
45.40%
0.76
43.07%
invested capital
-0.02
-
0.38
1,839.66%
0.37
2.36%
0.64
74.12%
4.72
631.59%
-0.17
103.53%
-0.18
10.28%
0.08
144.62%
-0.00
101.87%
-0.03
2,170.65%
market cap
923.61M
-
486.33M
47.34%
1.38B
183.51%
1.44B
4.18%
1.04B
27.62%
702.71M
32.41%
440.80M
37.27%
379.08M
14.00%
573.87M
51.39%
316.55M
44.84%
338.33M
6.88%
net current asset value
30.56M
-
181.63M
494.39%
163.42M
10.03%
39.65M
75.74%
-62.44M
257.48%
-137.22M
119.75%
37.14M
127.07%
110.30M
196.99%
65.61M
40.52%
63.69M
2.92%
net debt to ebitda
1.03
-
2.77
169.72%
-35.93
1,396.41%
1.81
105.03%
0.49
72.84%
-0.85
273.42%
1.21
242.33%
0.64
46.81%
0.71
10.24%
-0.09
112.70%
net income per share
-1.42
-
-1.31
7.52%
-0.05
96.56%
-1.36
2,912.79%
-1.23
9.94%
-1.14
7.11%
1.23
207.56%
-0.63
151.68%
-0.61
4.29%
-0.62
2.68%
-0.79
27.62%
operating cash flow per share
-1.24
-
-0.99
20.28%
1.78
280.08%
-1.69
194.80%
-1.76
4.18%
-1.40
20.29%
1.07
176.30%
-1.29
220.38%
-0.60
53.68%
-0.54
10.26%
payables turnover
0.03
-
0.14
325.84%
0.27
89.15%
0.35
32.94%
receivables turnover
2.81
-
22.08
685.06%
142.72
546.32%
11.12
92.21%
18.72
68.31%
10.67
43.01%
5.70
46.61%
60.75
966.26%
21.29
64.96%
4.96
76.68%
research and ddevelopement to revenue
40.36
-
3.91
90.32%
0.73
81.26%
2.14
191.99%
1.74
18.80%
1.59
8.64%
0.29
82.00%
6.40
2,143.13%
184.72
2,785.22%
379.97
105.70%
48.91
87.13%
return on tangible assets
-0.59
-
-0.27
54.59%
-0.01
96.87%
-0.37
4,353.83%
-0.38
1.34%
-0.64
67.68%
0.37
157.87%
-0.44
219.71%
-0.96
116.83%
-0.69
27.94%
revenue per share
0.03
-
0.30
887.51%
1.26
319.28%
0.80
36.07%
0.86
6.98%
0.60
30.42%
3.03
407.68%
0.22
92.86%
0.00
99.05%
0.00
59.01%
0.01
549.19%
roe
0.10
-
-0.35
440.48%
-0.02
95.36%
-0.90
5,385.77%
-2.48
175.66%
0.08
103.31%
-0.10
218.42%
-0.45
362.67%
0.06
113.22%
0.06
9.34%
roic
0.10
-
-0.26
347.63%
0.01
103.34%
-0.55
6,496.84%
-0.42
23.55%
0.09
120.73%
-0.14
256.43%
-1.26
827.77%
0.06
104.70%
0.07
12.97%
sales general and administrative to revenue
7.71
-
0.85
88.98%
0.18
78.42%
0.52
181.74%
0.73
41.89%
1.01
37.63%
345.92
-
shareholders equity per share
-13.70
-
3.72
127.16%
2.76
25.82%
1.52
45.08%
0.50
67.33%
-13.91
2,908.59%
-12.63
9.18%
1.41
111.17%
-10.21
824.04%
-9.59
6.09%
stock based compensation to revenue
3.34
-
0.31
90.72%
0.05
83.01%
0.09
69.89%
0.10
17.26%
0.19
76.47%
0.04
76.14%
0.55
1,153.13%
35.49
6,316.01%
82.88
133.50%
tangible asset value
72.06M
-
186.12M
158.27%
187.95M
0.98%
59.50M
68.34%
-44.33M
174.50%
-121.07M
173.13%
52.84M
143.65%
111.83M
111.63%
69.05M
38.25%
72.58M
5.11%
tangible book value per share
0.98
-
2.44
147.97%
1.81
25.57%
0.57
68.43%
-0.42
173.52%
-1.14
171.60%
0.50
143.49%
1.01
102.80%
0.47
53.01%
0.44
7.63%
working capital
115.26M
-
324.02M
181.12%
409.40M
26.35%
193.23M
52.80%
197.87M
2.40%
136.57M
30.98%
272.41M
99.46%
110.91M
59.28%
66.80M
39.78%
117.69M
76.20%

All numbers in USD (except ratios and percentages)